Nov 19 (Reuters) – Medivir AB: * MEDIVIR: FDA GRANTS MEDIVIR’S MIV-711 RARE PEDIATRIC DISEASE DESIGNATION FOR OSTEOGENESIS IMPERFECTA * MIV-711 MAY QUALIFY FOR PRIORITY REVIEW VOUCHER – TRANSFERABLE
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
By Gregor Stuart Hunter and Heekyong Yang SINGAPORE/SEOUL, Nov 19 (Reuters) - South Korea's biggest…
Nov 19 (Reuters) - The European Commission was targeted by a cyberattack which might have…
VIDEO SHOWS: ARCHIVE FOOTAGE OF KENYA'S WORLD MARATHON CHAMPION PERES JEPCHIRCHIR RESENDING WITH COMPLETE SHOTLIST…
Nov 19 (Reuters) - Close Brothers Group PLC: * CLOSE BROS GRP PLC - TRADING…
Vadodara (Gujarat) [India], November 18: Hon’ble Dr. Anandiben Patel, Governor of Uttar Pradesh visited Parul…
By Holger Hansen BERLIN, Nov 19 (Reuters) - UniCredit and Germany have reached agreement on…